JP Morgan Cautions Trade Tensions Are Weighing On Eastman Chemical Growth Prospects

1. JP Morgan downgraded EMN from Overweight to Neutral, lowering forecast to $76. 2. First-quarter EPS of $1.91 beat estimates, but sales were below expectations. 3. EMN anticipates Q2 EPS of $1.70-$1.90, below consensus of $2.18. 4. U.S.-China tariffs and maintenance will negatively impact Q2 earnings. 5. Analyst cuts 2025 EPS estimate to $7.40 from $8.45 amid trade uncertainties.